240 related articles for article (PubMed ID: 27793758)
1. Development and evaluation of accelerated drug release testing methods for a matrix-type intravaginal ring.
Externbrink A; Eggenreich K; Eder S; Mohr S; Nickisch K; Klein S
Eur J Pharm Biopharm; 2017 Jan; 110():1-12. PubMed ID: 27793758
[TBL] [Abstract][Full Text] [Related]
2. Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
Externbrink A; Clark MR; Friend DR; Klein S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):966-73. PubMed ID: 23791685
[TBL] [Abstract][Full Text] [Related]
3. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
[TBL] [Abstract][Full Text] [Related]
4. In vitro release testing methods for drug-releasing vaginal rings.
Boyd P; Variano B; Spence P; McCoy CF; Murphy DJ; Dallal Bashi YH; Malcolm RK
J Control Release; 2019 Nov; 313():54-69. PubMed ID: 31626862
[TBL] [Abstract][Full Text] [Related]
5. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
[TBL] [Abstract][Full Text] [Related]
6. Accelerated in vitro release testing method for a long-acting peptide-PLGA formulation.
Goel M; Leung D; Famili A; Chang D; Nayak P; Al-Sayah M
Eur J Pharm Biopharm; 2021 Aug; 165():185-192. PubMed ID: 33992753
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
8. Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism.
Tomic I; Vidis-Millward A; Mueller-Zsigmondy M; Cardot JM
Int J Pharm; 2016 May; 505(1-2):42-51. PubMed ID: 27025293
[TBL] [Abstract][Full Text] [Related]
9. A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.
Su JT; Teller RS; Srinivasan P; Zhang J; Martin A; Sung S; Smith JM; Kiser PF
Pharm Res; 2017 Oct; 34(10):2163-2171. PubMed ID: 28770490
[TBL] [Abstract][Full Text] [Related]
10. Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release.
Teller RS; Malaspina DC; Rastogi R; Clark JT; Szleifer I; Kiser PF
J Control Release; 2016 Feb; 224():176-183. PubMed ID: 26723526
[TBL] [Abstract][Full Text] [Related]
11. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
[TBL] [Abstract][Full Text] [Related]
12. Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets.
Kader A; Jalil R
Drug Dev Ind Pharm; 1998 Jun; 24(6):535-9. PubMed ID: 9876619
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro/in vivo evaluation of gestodene (GEST) intravaginal ring.
Li C; Ning M; Yao X; Wang Y; Liu Y
Pak J Pharm Sci; 2016 Sep; 29(5):1545-1553. PubMed ID: 27731811
[TBL] [Abstract][Full Text] [Related]
14. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
[TBL] [Abstract][Full Text] [Related]
15. Application of the Refined Integral Method in the mathematical modeling of drug delivery from one-layer torus-shaped devices.
Helbling IM; Ibarra JC; Luna JA
Int J Pharm; 2012 Feb; 423(2):240-6. PubMed ID: 22178126
[TBL] [Abstract][Full Text] [Related]
16. An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
Kulinowski P; Dorozyński P; Jachowicz R; Weglarz WP
J Pharm Biomed Anal; 2008 Nov; 48(3):685-93. PubMed ID: 18715732
[TBL] [Abstract][Full Text] [Related]
17. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
[TBL] [Abstract][Full Text] [Related]
18. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
Lu Z; Fassihi R
AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
[TBL] [Abstract][Full Text] [Related]
20. Influence of ethanol on aspirin release from hypromellose matrices.
Roberts M; Cespi M; Ford JL; Dyas AM; Downing J; Martini LG; Crowley PJ
Int J Pharm; 2007 Mar; 332(1-2):31-7. PubMed ID: 17084050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
